Liver Cancer Clinical Trials in South Dakota

Liver Cancer clinical trials in South Dakota

1 actively recruiting liver cancer trials at 1 site across South Dakota.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 2 Recruiting Academic/Other

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer that cannot be removed by surgery (unr…

Sponsor: Academic and Community Cancer Research United

NCT ID: NCT05168163

Sites in South Dakota:

Rapid City Regional Hospital — Rapid City, South Dakota

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20